{
    "xml": "<topic id=\"PHP8204\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/glycopyrronium-bromide\" basename=\"glycopyrronium-bromide\" title=\"GLYCOPYRRONIUM BROMIDE\">\n<title>GLYCOPYRRONIUM BROMIDE</title>\n<body>\n<data name=\"vtmid\">22168005</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_567112641\" title=\"Antimuscarinics\">Antimuscarinics</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34659\" title=\"ANTIMUSCARINICS (SYSTEMIC)\" namespace=\"/drug-classes/antimuscarinics-systemic\">ANTIMUSCARINICS (SYSTEMIC)</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34556\" title=\"ANTIMUSCARINICS (INHALED)\" namespace=\"/drug-classes/antimuscarinics-inhaled\">ANTIMUSCARINICS (INHALED)</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\n<data name=\"secondaryDomainsOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n<data name=\"domainOfEffect\">  </data>\n</data>\n<p outputclass=\"synonyms\">Glycopyrrolate</p>\n</body>\n<topic id=\"PHP70560\" outputclass=\"indicationsAndDose\" rev=\"1.17\" parent=\"/drugs/glycopyrronium-bromide\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Iontophoretic treatment of hyperhidrosis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">To the skin</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Only 1 site to be treated at a time, mximum 2 sites treated in any 24 hours, treatment not to be repeated within 7 days (consult product literature).</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Premedication at induction</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intramuscular injection or by intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>200&#8211;400&#8239;micrograms, alternatively 4&#8211;5&#8239;micrograms/kg (max. per dose 400&#8239;micrograms).</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Intra-operative bradycardia</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>200&#8211;400&#8239;micrograms, alternatively 4&#8211;5&#8239;micrograms/kg (max. per dose 400&#8239;micrograms), repeated if necessary.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Control of muscarinic side-effects of neostigmine in reversal of non-depolarising neuromuscular block</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>10&#8211;15&#8239;micrograms/kg, alternatively, 200&#8239;micrograms per 1&#8239;mg of neostigmine to be administered.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Bowel colic in palliative care</p>\n<p outputclass=\"therapeuticIndication\">Excessive respiratory secretions in palliative care</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By subcutaneous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>200&#8239;micrograms every 4&#8239;hours and when required, hourly use is occasionally necessary, particularly in excessive respiratory secretions.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By subcutaneous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>0.6&#8211;1.2&#8239;mg/24 hours.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Maintenance treatment of chronic obstructive pulmonary disease</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By inhalation of powder</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>50&#8239;micrograms once daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"doseEquivalence\">\n<title>Dose equivalence and conversion</title>\n<p>For inhalation of powder, each 50&#8239;microgram capsule of glycopyrronium delivers 44&#8239;micrograms of glycopyrronium.</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70658\" outputclass=\"importantSafetyInformation\" rev=\"1.18\" parent=\"/drugs/glycopyrronium-bromide\">\n<title>Important safety information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Antimuscarininc drugs used for premedication to general anaesthesia should only be administered by, or under the direct supervision of, personnel experienced in their use.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70664\" outputclass=\"contraindications\" rev=\"1.17\" parent=\"/drugs/glycopyrronium-bromide\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<sectiondiv outputclass=\"additionalContraindications\">\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\n<p outputclass=\"title\">With topical use</p>\n<p>\n<ph outputclass=\"contraindication\">infections affecting the treatment site</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"importantAdvice\">\n<title>Contra-indications, further information</title>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">topical</ph> use</p>\n<p outputclass=\"title\">Topical use</p>\n<p>Contra-indications applicable to systemic use should be considered; however, glycopyrronium is poorly absorbed and systemic effects unlikely with topical use.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70690\" outputclass=\"cautions\" rev=\"1.16\" parent=\"/drugs/glycopyrronium-bromide\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<sectiondiv outputclass=\"additionalCautions\">\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\n<p outputclass=\"title\">When used by inhalation</p>\n<p>\n<ph outputclass=\"caution\">arrhythmia (excluding chronic stable atrial fibrillation)</ph>; <ph outputclass=\"caution\">history of myocardial infarction</ph>; <ph outputclass=\"caution\">history of QT-interval prolongation</ph>; <ph outputclass=\"caution\">left ventricular failure</ph>; <ph outputclass=\"caution\">unstable ischaemic heart disease</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"importantAdvice\">\n<title>Cautions, further information</title>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">topical</ph> use</p>\n<p outputclass=\"title\">Topical use</p>\n<p>Cautions applicable to systemic use should be considered; however, glycopyrronium is poorly absorbed and systemic effects unlikely with topical use.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70504\" outputclass=\"sideEffects\" rev=\"1.21\" parent=\"/drugs/glycopyrronium-bromide\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"specificSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">When used by inhalation</p>\n<p>\n<ph outputclass=\"sideEffect\">insomnia</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">When used by inhalation</p>\n<p>\n<ph outputclass=\"sideEffect\">epistaxis</ph>; <ph outputclass=\"sideEffect\">hyperglycaemia</ph>; <ph outputclass=\"sideEffect\">hypoaesthesia</ph>; <ph outputclass=\"sideEffect\">malaise</ph>; <ph outputclass=\"sideEffect\">rhinitis</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">With topical use</p>\n<p>\n<ph outputclass=\"sideEffect\">tingling at administration site</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">topical</ph> use</p>\n<p outputclass=\"title\">Topical use</p>\n<p>The possibility of systemic side-effects should be considered; however; glycopyrrhonium is poorly absorbed and systemic effects unlikely with topical use.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70539\" outputclass=\"pregnancy\" parent=\"/drugs/glycopyrronium-bromide\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p outputclass=\"specificity\">When used by <ph outputclass=\"route\">inhalation</ph>\n</p>\n<p>Manufacturer advises use only if potential benefit outweighs risk.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70697\" outputclass=\"breastFeeding\" parent=\"/drugs/glycopyrronium-bromide\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p outputclass=\"specificity\">When used by <ph outputclass=\"route\">inhalation</ph>\n</p>\n<p>Manufacturer advises use only if potential benefit outweighs risk.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70522\" outputclass=\"renalImpairment\" parent=\"/drugs/glycopyrronium-bromide\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p outputclass=\"specificity\">When used by <ph outputclass=\"route\">inhalation</ph>\n</p>\n<p>Use with caution if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70535\" outputclass=\"patientAndCarerAdvice\" rev=\"1.9\" parent=\"/drugs/glycopyrronium-bromide\">\n<title>Patient and carer advice</title>\n<body>\n<section outputclass=\"generalPatientAdvice\">\n<sectiondiv>\n<p outputclass=\"specificity\">When used by <ph outputclass=\"route\">inhalation</ph>\n</p>\n<p>Patients or carers should be given advice on how to administer glycopyrronium for inhalation.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP8204-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/glycopyrronium-bromide\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: oral suspension, oral solution, cream, capsule, ointment, liquid</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75142\" title=\"Tablet\" namespace=\"/drugs/glycopyrronium-bromide/tablet\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75128\" title=\"Solution for injection\" namespace=\"/drugs/glycopyrronium-bromide/solution-for-injection\">Solution for injection</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75156\" title=\"Inhalation powder\" namespace=\"/drugs/glycopyrronium-bromide/inhalation-powder\">Inhalation powder</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75135\" title=\"Powder for solution for iontophoresis\" namespace=\"/drugs/glycopyrronium-bromide/powder-for-solution-for-iontophoresis\">Powder for solution for iontophoresis</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP88068\" namespace=\"/drugs/glycopyrronium-bromide-with-neostigmine\" title=\"GLYCOPYRRONIUM BROMIDE WITH NEOSTIGMINE\" count=\"1\" rel=\"backlink\">GLYCOPYRRONIUM BROMIDE WITH NEOSTIGMINE</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP107735\" namespace=\"/guidance/prescribing-in-palliative-care\" title=\"Prescribing in palliative care\" count=\"3\" rel=\"backlink\">Prescribing in palliative care</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78384\" namespace=\"/treatment-summaries/antiperspirants\" title=\"Antiperspirants\" count=\"1\" rel=\"backlink\">Antiperspirants</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78426\" namespace=\"/treatment-summaries/neuromuscular-blockade\" title=\"Neuromuscular blockade\" count=\"1\" rel=\"backlink\">Neuromuscular blockade</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78465\" namespace=\"/treatment-summaries/bronchodilators\" title=\"Bronchodilators\" count=\"1\" rel=\"backlink\">Bronchodilators</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78500\" namespace=\"/treatment-summaries/pre-medication-and-peri-operative-drugs\" title=\"Pre-medication and peri-operative drugs\" count=\"1\" rel=\"backlink\">Pre-medication and peri-operative drugs</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34659\" namespace=\"/drug-classes/antimuscarinics-systemic\" title=\"ANTIMUSCARINICS (SYSTEMIC)\" count=\"1\" rel=\"link\">ANTIMUSCARINICS (SYSTEMIC)</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34556\" namespace=\"/drug-classes/antimuscarinics-inhaled\" title=\"ANTIMUSCARINICS (INHALED)\" count=\"1\" rel=\"link\">ANTIMUSCARINICS (INHALED)</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75142\" namespace=\"/drugs/glycopyrronium-bromide/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75128\" namespace=\"/drugs/glycopyrronium-bromide/solution-for-injection\" title=\"Solution for injection\" count=\"1\" rel=\"link\">Solution for injection</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75156\" namespace=\"/drugs/glycopyrronium-bromide/inhalation-powder\" title=\"Inhalation powder\" count=\"1\" rel=\"link\">Inhalation powder</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75135\" namespace=\"/drugs/glycopyrronium-bromide/powder-for-solution-for-iontophoresis\" title=\"Powder for solution for iontophoresis\" count=\"1\" rel=\"link\">Powder for solution for iontophoresis</xref>\n</links>\n</topic>",
    "id": "PHP8204",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/glycopyrronium-bromide",
    "basename": "glycopyrronium-bromide",
    "title": "GLYCOPYRRONIUM BROMIDE",
    "vtmid": "22168005",
    "drugClassification": [
        "Antimuscarinics"
    ],
    "inheritsFromClass": [
        "ANTIMUSCARINICS (SYSTEMIC)",
        "ANTIMUSCARINICS (INHALED)"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "secondaryDomainsOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "synonyms": [
        "Glycopyrrolate"
    ],
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Iontophoretic treatment of hyperhidrosis",
                        "html": "Iontophoretic treatment of hyperhidrosis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "To the skin"
                    ],
                    "textContent": "To the skin",
                    "html": "To the skin"
                },
                "adult": [
                    {
                        "textContent": "Only 1 site to be treated at a time, mximum 2 sites treated in any 24 hours, treatment not to be repeated within 7 days (consult product literature).",
                        "html": "<p>Only 1 site to be treated at a time, mximum 2 sites treated in any 24 hours, treatment not to be repeated within 7 days (consult product literature).</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Premedication at induction",
                        "html": "Premedication at induction"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intramuscular injection or intravenous injection"
                    ],
                    "textContent": "By intramuscular injection or by intravenous injection",
                    "html": "By intramuscular injection or by intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "200&#8211;400 micrograms, alternatively 4&#8211;5 micrograms/kg (max. per dose 400 micrograms).",
                        "html": "<p>200&#8211;400&#8239;micrograms, alternatively 4&#8211;5&#8239;micrograms/kg (max. per dose 400&#8239;micrograms).</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Intra-operative bradycardia",
                        "html": "Intra-operative bradycardia"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous injection"
                    ],
                    "textContent": "By intravenous injection",
                    "html": "By intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "200&#8211;400 micrograms, alternatively 4&#8211;5 micrograms/kg (max. per dose 400 micrograms), repeated if necessary.",
                        "html": "<p>200&#8211;400&#8239;micrograms, alternatively 4&#8211;5&#8239;micrograms/kg (max. per dose 400&#8239;micrograms), repeated if necessary.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Control of muscarinic side-effects of neostigmine in reversal of non-depolarising neuromuscular block",
                        "html": "Control of muscarinic side-effects of neostigmine in reversal of non-depolarising neuromuscular block"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous injection"
                    ],
                    "textContent": "By intravenous injection",
                    "html": "By intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "10&#8211;15 micrograms/kg, alternatively, 200 micrograms per 1 mg of neostigmine to be administered.",
                        "html": "<p>10&#8211;15&#8239;micrograms/kg, alternatively, 200&#8239;micrograms per 1&#8239;mg of neostigmine to be administered.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Bowel colic in palliative care",
                        "html": "Bowel colic in palliative care"
                    },
                    {
                        "textContent": "Excessive respiratory secretions in palliative care",
                        "html": "Excessive respiratory secretions in palliative care"
                    }
                ],
                "specificity": {
                    "routes": [
                        "subcutaneous infusion"
                    ],
                    "textContent": "By subcutaneous infusion",
                    "html": "By subcutaneous infusion"
                },
                "adult": [
                    {
                        "textContent": "200 micrograms every 4 hours and when required, hourly use is occasionally necessary, particularly in excessive respiratory secretions.",
                        "html": "<p>200&#8239;micrograms every 4&#8239;hours and when required, hourly use is occasionally necessary, particularly in excessive respiratory secretions.</p>"
                    },
                    {
                        "textContent": "0.6&#8211;1.2 mg/24 hours.",
                        "html": "<p>0.6&#8211;1.2&#8239;mg/24 hours.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Maintenance treatment of chronic obstructive pulmonary disease",
                        "html": "Maintenance treatment of chronic obstructive pulmonary disease"
                    }
                ],
                "specificity": {
                    "routes": [
                        "inhalation of powder"
                    ],
                    "textContent": "By inhalation of powder",
                    "html": "By inhalation of powder"
                },
                "adult": [
                    {
                        "textContent": "50 micrograms once daily.",
                        "html": "<p>50&#8239;micrograms once daily.</p>"
                    }
                ]
            }
        ],
        "doseEquivalence": [
            {
                "type": "doseEquivalence",
                "title": "Dose equivalence and conversion",
                "textContent": "For inhalation of powder, each 50 microgram capsule of glycopyrronium delivers 44 micrograms of glycopyrronium.",
                "html": "<p>For inhalation of powder, each 50&#8239;microgram capsule of glycopyrronium delivers 44&#8239;micrograms of glycopyrronium.</p>"
            }
        ]
    },
    "importantSafetyInformation": {
        "importantSafetyInformation": [
            {
                "type": "importantSafetyInformation",
                "textContent": "Antimuscarininc drugs used for premedication to general anaesthesia should only be administered by, or under the direct supervision of, personnel experienced in their use.",
                "html": "<p>Antimuscarininc drugs used for premedication to general anaesthesia should only be administered by, or under the direct supervision of, personnel experienced in their use.</p>"
            }
        ]
    },
    "contraindications": {
        "cautionsOrContraindicationsWithRoutes": [
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "infections affecting the treatment site",
                "html": "infections affecting the treatment site",
                "specificity": {
                    "textContent": "With topical use",
                    "html": "With topical use",
                    "routes": [
                        "topical"
                    ]
                }
            }
        ],
        "importantAdvice": [
            {
                "type": "importantAdvice",
                "specificity": {
                    "textContent": "With topical use",
                    "html": "With <ph outputclass=\"route\">topical</ph> use",
                    "routes": [
                        "topical"
                    ]
                },
                "title": "Topical use",
                "textContent": "Contra-indications applicable to systemic use should be considered; however, glycopyrronium is poorly absorbed and systemic effects unlikely with topical use.",
                "html": "<p>Contra-indications applicable to systemic use should be considered; however, glycopyrronium is poorly absorbed and systemic effects unlikely with topical use.</p>"
            }
        ]
    },
    "cautions": {
        "cautionsOrContraindicationsWithRoutes": [
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "arrhythmia (excluding chronic stable atrial fibrillation)",
                "html": "arrhythmia (excluding chronic stable atrial fibrillation)",
                "specificity": {
                    "textContent": "When used by inhalation",
                    "html": "When used by inhalation",
                    "routes": [
                        "inhalation"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "history of myocardial infarction",
                "html": "history of myocardial infarction",
                "specificity": {
                    "textContent": "When used by inhalation",
                    "html": "When used by inhalation",
                    "routes": [
                        "inhalation"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "history of QT-interval prolongation",
                "html": "history of QT-interval prolongation",
                "specificity": {
                    "textContent": "When used by inhalation",
                    "html": "When used by inhalation",
                    "routes": [
                        "inhalation"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "left ventricular failure",
                "html": "left ventricular failure",
                "specificity": {
                    "textContent": "When used by inhalation",
                    "html": "When used by inhalation",
                    "routes": [
                        "inhalation"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "unstable ischaemic heart disease",
                "html": "unstable ischaemic heart disease",
                "specificity": {
                    "textContent": "When used by inhalation",
                    "html": "When used by inhalation",
                    "routes": [
                        "inhalation"
                    ]
                }
            }
        ],
        "importantAdvice": [
            {
                "type": "importantAdvice",
                "specificity": {
                    "textContent": "With topical use",
                    "html": "With <ph outputclass=\"route\">topical</ph> use",
                    "routes": [
                        "topical"
                    ]
                },
                "title": "Topical use",
                "textContent": "Cautions applicable to systemic use should be considered; however, glycopyrronium is poorly absorbed and systemic effects unlikely with topical use.",
                "html": "<p>Cautions applicable to systemic use should be considered; however, glycopyrronium is poorly absorbed and systemic effects unlikely with topical use.</p>"
            }
        ]
    },
    "sideEffects": {
        "specific": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "insomnia",
                        "html": "insomnia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "When used by inhalation",
                            "html": "When used by inhalation",
                            "routes": [
                                "inhalation"
                            ]
                        }
                    }
                ],
                "uncommon": [
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "epistaxis",
                        "html": "epistaxis",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "When used by inhalation",
                            "html": "When used by inhalation",
                            "routes": [
                                "inhalation"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "hyperglycaemia",
                        "html": "hyperglycaemia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "When used by inhalation",
                            "html": "When used by inhalation",
                            "routes": [
                                "inhalation"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "hypoaesthesia",
                        "html": "hypoaesthesia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "When used by inhalation",
                            "html": "When used by inhalation",
                            "routes": [
                                "inhalation"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "malaise",
                        "html": "malaise",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "When used by inhalation",
                            "html": "When used by inhalation",
                            "routes": [
                                "inhalation"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "rhinitis",
                        "html": "rhinitis",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "When used by inhalation",
                            "html": "When used by inhalation",
                            "routes": [
                                "inhalation"
                            ]
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "tingling at administration site",
                        "html": "tingling at administration site",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With topical use",
                            "html": "With topical use",
                            "routes": [
                                "topical"
                            ]
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "specificity": {
                    "textContent": "With topical use",
                    "html": "With <ph outputclass=\"route\">topical</ph> use",
                    "routes": [
                        "topical"
                    ]
                },
                "title": "Topical use",
                "textContent": "The possibility of systemic side-effects should be considered; however; glycopyrrhonium is poorly absorbed and systemic effects unlikely with topical use.",
                "html": "<p>The possibility of systemic side-effects should be considered; however; glycopyrrhonium is poorly absorbed and systemic effects unlikely with topical use.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "specificity": {
                    "textContent": "When used by inhalation",
                    "html": "When used by <ph outputclass=\"route\">inhalation</ph>",
                    "routes": [
                        "inhalation"
                    ]
                },
                "textContent": "Manufacturer advises use only if potential benefit outweighs risk.",
                "html": "<p>Manufacturer advises use only if potential benefit outweighs risk.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "specificity": {
                    "textContent": "When used by inhalation",
                    "html": "When used by <ph outputclass=\"route\">inhalation</ph>",
                    "routes": [
                        "inhalation"
                    ]
                },
                "textContent": "Manufacturer advises use only if potential benefit outweighs risk.",
                "html": "<p>Manufacturer advises use only if potential benefit outweighs risk.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "specificity": {
                    "textContent": "When used by inhalation",
                    "html": "When used by <ph outputclass=\"route\">inhalation</ph>",
                    "routes": [
                        "inhalation"
                    ]
                },
                "textContent": "Use with caution if eGFR less than 30 mL/minute/1.73 m2.",
                "html": "<p>Use with caution if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "specificity": {
                    "textContent": "When used by inhalation",
                    "html": "When used by <ph outputclass=\"route\">inhalation</ph>",
                    "routes": [
                        "inhalation"
                    ]
                },
                "textContent": "Patients or carers should be given advice on how to administer glycopyrronium for inhalation.",
                "html": "<p>Patients or carers should be given advice on how to administer glycopyrronium for inhalation.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "oral suspension",
                "oral solution",
                "cream",
                "capsule",
                "ointment",
                "liquid"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP75142",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75128",
                "label": "Solution for injection",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75156",
                "label": "Inhalation powder",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75135",
                "label": "Powder for solution for iontophoresis",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drug": [
            {
                "id": "PHP88068",
                "label": "GLYCOPYRRONIUM BROMIDE WITH NEOSTIGMINE",
                "type": "drug"
            }
        ],
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP107735",
                "label": "Prescribing in palliative care",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78384",
                "label": "Antiperspirants",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78426",
                "label": "Neuromuscular blockade",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78465",
                "label": "Bronchodilators",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78500",
                "label": "Pre-medication and peri-operative drugs",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "drugClass": [
            {
                "id": "PHP34659",
                "label": "ANTIMUSCARINICS (SYSTEMIC)",
                "type": "drugClass"
            },
            {
                "id": "PHP34556",
                "label": "ANTIMUSCARINICS (INHALED)",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP75142",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75128",
                "label": "Solution for injection",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75156",
                "label": "Inhalation powder",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75135",
                "label": "Powder for solution for iontophoresis",
                "type": "medicinalForm"
            }
        ]
    }
}